α-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats

Phytomedicine

Volumn 10, Issue 5, 2003, Pages 397-404

  Rodriguez Paez L ^a   Juarez Sanchez M ^a   Antunez Solis J ^a   Baeza, I ^a   Wong, C ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Bile flow; CSI; HMG CoA reductase inhibitor; Hypocholesterolemic; Lipoproteins; asarone

Indexed keywords

ALPHA ASARONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; BILE SECRETION; BLOOD SAMPLING; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG ELIMINATION; ENZYME INHIBITION; GALLSTONE; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0037870337     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00274     Document Type: Article

References (34)

1. Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (1988) The liver, Biology and pathobiology. Raven Press. N. Y.
2. Beg ZH, Stonik JA, Brewer HB (1977) Purification and characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from chicken liver. FEBS Lett 80: 123-129
3. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47
4. Carey MC, Small DM (1970) The characteristics of mixed micellar solution with particular reference to bile. Am J Med 49: 590-608
5. Carey MC (1978) Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19: 998-1026
6. Clerc T, Jomier M, Chautan M, Portugal H, Senft M, Pauli A, Laruelle C, Morel O, Lafont H, Chanussot F (1993) Mechanism of action in the liver of crilvastatin: a new hydroxy-methylglutaryl-coenzyme A reductase inhibitor. Eur J Pharm. 235: 59-68
7. Corsini A, Raiteri M, Soma MR, Bernini F, Fumagalli R, Paoletti R (1995) Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol 76: 21-28
8. Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JI (1972) Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286: 1-8
9. Díaz F, Contreras I, Flores R, Tamariz J, Labarrios F, Chamorro G, Muñoz H (1990) An efficient synthesis of alpha asarone. Org Prep Proc Int 23: 133-138
10. Duane WC, Hunningnake DB, Freeman ML, Pooler PA, Schlojner L, Gebhurd RL (1988) Simvastatin, a competitive inhibitor of HMG CoA reductase lowers cholesterol saturation index of gallbladder bile. Hepatology 8: 1147-1150
11. Duane WC, Levitt MD, Elson SKJ (1993) Facilitated method measurement of biliary secretion rates in healthy human. J Lipid Res 34: 859-863
12. Enríquez RG, Chávez MA, Jáuregui F (1980) Propenylbenzenes from Guatteria gaumeri. Phytochemistry 19: 2024-2425
13. Garduño L, Salazar M, Salazar S, Morelos ME, Labarrios F, Tamariz J, Chamorro GA (1997) Hypolipidaemic activity of alpha-asarone in mice. J Ethnopharmacol 55: 161-163
14. Gómez C, Chamorro G, Chávez MA, Martínez G, Salazar M, Pages N (1987) Effect de l'alpha-asarone sur hypercholesterolemic et la cholelitiasis experimentales. Plant Med Phytother 21: 279-284
15. Heller RA, Shrewsbery MA (1976) 3-hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. J Biol Chem 251: 3815-3822
16. Hensley WJ, Mansfield CH (1999) Lipoproteins, atherogenicity, age and risk of myocardial infarction. Aust N Z Public Health 23: 174-178
17. Hoogerbrugge VD, Linden N, de Rooy FWM, Jansen H, van Blankenstein M (1990) Effect of pravastatin on biliary lipid composition and bile synthesis in familiar hypercholesterolemia. Gut 31: 348-350
18. Jones MP, Pandak WM, Heuman DM, Chang JY, Hylemon PB, Blahcevic ZR (1992) Cholesterol 7-alpha-hydroxylase: evidence for transcriptional regulation by cholesterol or metabolic products of cholesterol in the rat. J Lipid Res 34: 385-892
19. Kleinsek A, Ranganathan S, Porter JW (1977) Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver. Proc Natl Acad Sci (USA) 74: 1431-1435
20. Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241
21. Mandoki JJ, Krumm-Heller C, Vega-Noverola J, Wong-Ramírez C, Arriaga C, Roa R, Rubio C, Mendoza-Patiño N (1980) Isolation of α-asarone from the bark of Guatteria gaumeri (Elemuy) and the study of its hypocholesterolemic effect. IV National Congress of Pharmacology, University of Yucatán. Mérida, Yucatán, México
22. a ed. México. Ed. Botas
23. Mitchell JC, Logan GM, Stone BG, Duane NC (1991) Effect of lovastatin on biliary secretion and bile acid metabolism in humans. J Lipid Res 32: 71-78
24. Poplawski J, Lozowicka B, Dubis AT, Lachowska B, Witkowski S, Siluk D, Petrusewicz J, Kaliszan R, Cybulski J, Strzalkowska M, Chilmoneczyk Z (2000) Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). J Med Chem 43: 3671-3676
25. Roach PD, Balasubramaniam S, Hirata F, Abbey M, Szanto A, Simons LA, Nestel PJ (1993) The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim Biophys Acta 1170: 165-172
26. Sánchez-Reséndiz J, Lerdo de Tejada A, González-Vite J, Guzmán R, Tinoco A, Karchmer S (1980) Acción hipocolesterolemiante de Guatteria gaumeri. Med Trad 3: 20-22
27. Seshadri TR, Thiruvengadam TR (1950) A new synthesis of asarone. Proc Ind Acad Sci 32A: 110-113
28. Small DM (1970) The formation of gallstones. Adv Intern Med 16: 243-264
29. Smith OJ, Erkelens DW, Von Berger Henegorwen GP (1992) Successful dissolution of cholesterol gallstones during treatment with pravastatin. Gastroenterol 103: 1068-1070
30. Spady DK, Cuthbert JA (1992) Regulation of hepatic sterol metabolism in the rat. Parallel regulation of activity and mRNA for 7 alpha-hydroxylase but not 3-hydroxy-3-methyglutaryl coenzyme A reductase or low density lipiprotein receptor. J Biol Chem 267: 5584-5591
31. Straka MS, Junker LH, Zacarro L, Zogg DR, Dueland S, Everson GT, Davis RAJ (1990) Substrate stimulation of 7-alpha-hydroxylase, an enzyme located in the cholesterol-poor endoplasmic reticulum. J Biol Chem 265: 7145-7149
32. Vivancos-Mora J, Leon-Colombo T, Monforte-Dupret C (1999) Hypolipemic treatment in the prevention of atherosclerotic plaque complications. Rev Neurol 29: 857-863
33. Vlahcevic ZR, Heuman DM, Hylemon PB (1991) Regulation of bile acid synthesis. Hepatology 13: 590-600
34. Wierzbicki AJ (2001) Atorvastatin. Expert Opin Pharmacother 2: 819-830